Table 2.
The effect of peritoneal dialysis regimen adjustments on residual renal function and volume in the ARNI subgroup during the one-year observation period.
| Without adjustments |
p value* | With adjustments |
p value* | |||
|---|---|---|---|---|---|---|
| Baseline | 12-month | Baseline | 12-month | |||
| NT-proBNP | 5,959.50 (2206.00, 9713.00) | 3,227.00 (198.00, 6256.00) | 0.005 | 11,720.50 (3451.00, 25197.00) | 9,300.00 (555.00, 20253.00) | 0.959 |
| Weekly renal Kt/V | 0.33 (0.06, 0.61) |
0.19 (0.00, 0.52) |
0.289 | 0.59 (0.35, 0.82) |
0.22 (0.00, 0.72) |
0.600 |
Quantitative data was expressed as median with interquartile range (IQR). Bold indicates significance at p < 0.05.
Abbreviations: ARNI, angiotensin receptor-neprilysin inhibitor; NT-proBNP, N-terminal pro-B-type natriuretic peptide; weekly renal Kt/V, weekly renal fractional clearance index for urea.
*
The difference in volume and residual renal function between baseline and after 12-month of peritoneal dialysis regimen adjustment in ARNI subgroup.